Hypertension Trial, Recruiting NCT06845514 Sponsor: Université de Sherbrooke Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT06845514
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 50 and 70 years old
  • People who have not had a menstrual period for 12 months in a row (indicating they have gone through menopause)
  • People with blood pressure readings in the normal-high range or classified as stage 1 high blood pressure (confirm with trial site for exact numbers)
  • People who currently do less than 150 minutes of structured aerobic exercise (such as walking or cycling) per week
  • People who have not been doing regular weight or resistance training (2 or more sessions per week) for more than 3 months in the past year

Who may not be able to join:

  • People who have physical or joint problems that would prevent them from safely doing resistance exercise
  • People who have surgery planned during the study period
  • People with severely high blood pressure (readings of 160/100 mmHg or higher)
  • People who have been diagnosed with type 2 diabetes
  • People who have had a heart attack, stroke, or other heart or blood vessel event in the past 6 months, or whose recovery from such an event prevents them from exercising
  • People who have recently started hormone replacement therapy (within the past 4 months), where that therapy is known to affect blood pressure

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Eléonor Riesco, Ph.D., Université de Sherbrooke

Phone: 819-821-8000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Université de Sherbrooke
Registry
ClinicalTrials.gov
Start date
8 July 2025
Est. completion
1 May 2028

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Change in blood pressure post-exercise; Change in ambulatory blood pressure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov